Managed the Image Analysis Team in Clinical Operations. Provided leadership, technical training, forecast planning. Enforced compliance and reliability across research sites by participating in the quality control of MRI scanners and equipment across the country and the world. Consulted with research sites to resolve image quality issues and training for clinical trial image acquisition.
Utilized an in-house semi-automatic MRI masking system for volumetric analysis of clinical brain MRI images for use in quantify the effects of drug vs. placebo in three Phase III Alzheimer's Disease clinical trials. Helped manage the team's transition of additional DXA analysis capability from Portland, OR to Newark, CA in 2013.